Please use this identifier to cite or link to this item:
https://doi.org/10.1016/j.phrs.2023.106756
DC Field | Value | |
---|---|---|
dc.title | The role of tumor-derived extracellular vesicles containing noncoding RNAs in mediating immune cell function and its implications from bench to bedside | |
dc.contributor.author | Liu, CG | |
dc.contributor.author | Chen, J | |
dc.contributor.author | Goh, RMWJ | |
dc.contributor.author | Liu, YX | |
dc.contributor.author | Wang, L | |
dc.contributor.author | Ma, Z | |
dc.date.accessioned | 2023-06-09T09:43:04Z | |
dc.date.available | 2023-06-09T09:43:04Z | |
dc.date.issued | 2023-05-01 | |
dc.identifier.citation | Liu, CG, Chen, J, Goh, RMWJ, Liu, YX, Wang, L, Ma, Z (2023-05-01). The role of tumor-derived extracellular vesicles containing noncoding RNAs in mediating immune cell function and its implications from bench to bedside. Pharmacological Research 191 : 106756-. ScholarBank@NUS Repository. https://doi.org/10.1016/j.phrs.2023.106756 | |
dc.identifier.issn | 1043-6618 | |
dc.identifier.issn | 1096-1186 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/241807 | |
dc.description.abstract | Extracellular vesicles (EVs) are membrane-encapsulated vesicles released by almost all cell types, which participate in intercellular communication by delivering different types of molecular cargoes, such as non-coding RNAs (ncRNAs). Accumulating evidence suggests that tumor-derived EVs act as a bridge for intercellular crosstalk between tumor cells and surrounding cells, including immune cells. Tumor-derived EVs containing ncRNAs (TEV-ncRNAs) mediate intercellular crosstalk to manipulate immune responses and affect the malignant phenotypes of cancer cells. In this review, we summarize the double-edged roles and the underlying mechanisms of TEV-ncRNAs in regulating innate and adaptive immune cells. We also highlight the advantages of using TEV-ncRNAs in liquid biopsies for cancer diagnosis and prognosis. Moreover, we outline the use of engineered EVs to deliver ncRNAs and other therapeutic agents for cancer therapy. | |
dc.publisher | Elsevier BV | |
dc.source | Elements | |
dc.subject | Cancer therapy | |
dc.subject | Extracellular vesicles | |
dc.subject | Non-coding RNAs | |
dc.subject | Tumor immunity | |
dc.subject | Extracellular Vesicles | |
dc.subject | RNA, Untranslated | |
dc.subject | Immunity, Innate | |
dc.subject | Cell Communication | |
dc.type | Article | |
dc.date.updated | 2023-06-06T07:24:59Z | |
dc.contributor.department | MEDICINE | |
dc.contributor.department | CANCER SCIENCE INSTITUTE OF SINGAPORE | |
dc.description.doi | 10.1016/j.phrs.2023.106756 | |
dc.description.sourcetitle | Pharmacological Research | |
dc.description.volume | 191 | |
dc.description.page | 106756- | |
dc.published.state | Published | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
The role of tumor-derived extracellular vesicles containing noncoding RNAs in mediating immune cell function and its implications from bench to bedside.pdf | Published version | 9 MB | Adobe PDF | OPEN | None | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.